Think Tank 5

Time Dependence of Signalling Networks

Description:
General question: What can we learn about network architecture by studying time series of data? More specific question: How can we use this knowledge for the treatment of cancer? The time response of a network after a perturbation depends on its architecture. For signal transduction networks often the sample concentration of phosphorylated proteins is measured over time using (semi-) quantitative western blotting, e.g. after binding of a ligand to its plasma membrane receptor. Emergent properties like robustness, amplification, noise suppression and decisions for apoptosis, senescence, differentiation, etc. can eventually be deduced by mathematical modelling. Abnormalities in cellular signalling networks can disturb the balance between cell survival and cell death, resulting in cancer. Recently “addiction to an oncogene” has been recognized as a feature of some cancers becoming addicted to survival signalling by an overactive oncogene. Inhibition of the corresponding protein (often a kinase) activity or another node directly connected to that protein can lead to a dramatic anti-cancer response and lead to increased survival of the patient. It has been found that an oncogene can result in two opposing signals representing life and death of the cell. The life/death balance can vary over time after a perturbation. The study of the dynamics of this balance and the underlying biochemical reaction kinetics is extremely interesting with regard to translation to timing of perturbations by drugs during chemotherapy.

Membership:

TT5 - Convenor

Dr Jan Lankelma
Medical Systems Biology, Tumor Cell Biology, Dept of Molecular Cell Physiology, Faculty of Earth and Life Sciences (FALW), VU University Amsterdam (VU)
T: +31-20-444 2603 (+31-20-598 7248)   E: jan.lankelma@falw.vu.nl   W: www.falw.vu.nl

TT5 - Member

Dr Wim P.H. de Boer
Department Medical Oncology, VU University Medical Centre (VUmc)
T: +31-70-399 6929   E: wdeboer@ziggo.nl

TT5 - Member

Dr Frank J. Bruggeman
NISB Junior Group Leader, Systems Biology of Molecular Regulatory Networks, Life Sciences Group, Netherlands Institute for Systems Biology (NISB) & CWI & UvA-SILS
T: +31-20-592 4077 (+31-20-598 7738)   E: frank.bruggeman@sysbio.nl   W: homepages.cwi.nl/~bruggema

TT5 - Member

Dr Anton Feenstra
Bioinformatics, Faculty of Sciences (FEW) & Faculty of Earth and Life Sciences (FALW) & Centre for Integrative Bioinformatics VU (IBIVU), VU University Amsterdam (VU)
T: +31-20-598 7738   E: feenstra@few.vu.nl   W: www.ibi.vu.nl

TT5 - Member

Prof. Dr Dorus W.J. Gadella
Section of Molecular Cytology & Centre for Advanced Microscopy, Swammerdam Institute for Life Sciences (SILS), Faculty of Science (FNWI), University of Amsterdam (UvA)
T: +31-20-525 6259   E: th.w.j.gadella@uva.nl   W: wwwmc.bio.uva.nl

TT5 - Member

Dr Johan Westerhuis
BioSystems Data Analysis (BDA), Swammerdam Institute for Life Sciences (SILS), Faculty of Science (FNWI), University of Amsterdam (UvA)
T: +31-20-525 6546   E: j.a.westerhuis@uva.nl   W: www.bdagroup.nl

The Amsterdam Systems Biology cohort: 25 NISB Principal investigators
NISB is currently counting twenty-five principal investigators (25 PIs) who are colla...

Systems Biology research funding in the Netherlands
2010 July 31
An overview of grants shows that Dutch f...

Biophysics Award for PhD-thesis
2009 September 4
A new prize for the best PhD award in the bro...

Netherlands Institute for Systems Biology (NISB) - University of Amsterdam - Science Park 904 - 1098XH Amsterdam - nisb@sysbio.nl - Copyright © 2010 - All rights reserved